BioCryst Pharmaceuticals (BCRX) Fails to deliver data

Key failure to deliver metrics for BioCryst Pharmaceuticals :

• Last SEC data release: 2026-08-31
• Last 15 days FTD volume: $0.11 M
• Last 3 months FTD volume: $1.51 M
• Last 12 months FTD volume: $8.88 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for BioCryst Pharmaceuticals (BCRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for BioCryst Pharmaceuticals (BCRX) - since 2013

BioCryst Pharmaceuticals (BCRX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Gilead Sciences GILD	$5.28 M	$84.16 M	🇺🇸 USA
GSK plc GSK	$35.52 M	$0.17 B	🇬🇧 UK
Sarepta Therapeutics SRPT	$5 M	$23.13 M	🇺🇸 USA
Repligen RGEN	$21.74 M	$53.13 M	🇺🇸 USA
Novavax NVAX	$14.35 M	$59.52 M	🇺🇸 USA
Celldex Therapeutics CLDX	$0.8 M	$9.89 M	🇺🇸 USA
NanoViricides NNVC	$0.13 M	$2.94 M	🇺🇸 USA
Cel-Sci CVM	$0.47 M	$2.44 M	🇺🇸 USA
Emergent BioSolutions EBS	$4.13 M	$5.83 M	🇺🇸 USA